
Immunotherapy trial helps cancer patients with tumours live 40% longer
Cancer patients treated with a pioneering immunotherapy that genetically modifies their own cells to wipe out tumours live 40% longer, according to “exciting” and “groundbreaking” results from a world-first clinical trial. Car T-cell therapy is a new form …